Zhuhai United Bio-Pharmaceutical Co., Ltd. Reached Industry-University-Research Cooperation with the Department of Pharmacy of Beijing Tsinghua Changgung Hospital

THE GROUP’S PRODUCT ROXITHROMYCIN CAPSULES PASSED THE CONSISTENCY EVALUATION

APPROVAL FOR CLINICAL TRIAL OF UBT251 INJECTION ON INDICATION OF OSA

FDA APPROVAL OF IND FOR GROUP’S PRODUCT TUL108 FOR INJECTION

TUL Won "Outstanding High-Quality Development Listed Company"

The United Bio-Technology (Hengqin) Co., Ltd. Approved to Establish "Guangdong Endocrine and Metabolic Drug Engineering Technology Research Center"

TUL Won "Outstanding ESG Award"

The United Animal Healthcare (Inner Mongolia) Co., Ltd. Received Dual Honors of "Specialized, Sophisticated, Differentiated and Innovative Enterprise" and "Tech Innovation Leading Benchmark Enterprise"

TUL Received Two Honors at "HKEX 100"